BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35538067)

  • 1. FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1.
    Zhao X; Chen H; Qiu Y; Cui L
    Int J Oral Sci; 2022 May; 14(1):25. PubMed ID: 35538067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
    Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
    Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
    Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
    PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
    Roh V; Hiou-Feige A; Misetic V; Rivals JP; Sponarova J; Teh MT; Ferreira Lopes S; Truan Z; Mermod M; Monnier Y; Hess J; Tolstonog GV; Simon C
    J Pathol; 2020 Jan; 250(1):107-119. PubMed ID: 31465124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
    Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
    Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
    Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
    Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
    Waseem A; Ali M; Odell EW; Fortune F; Teh MT
    Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
    Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.
    Chen Y; Liu Y; Ni H; Ding C; Zhang X; Zhang Z
    Int J Oncol; 2017 Oct; 51(4):1045-1054. PubMed ID: 28848994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
    Umair A; Tarakji B; Ibrahim A; Nasser A; Fq A; Shreen A
    Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
    Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
    Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
    Xue K; Li J; Nan S; Zhao X; Xu C
    Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
    Ban Y; Tan P; Cai J; Li J; Hu M; Zhou Y; Mei Y; Tan Y; Li X; Zeng Z; Xiong W; Li G; Li X; Yi M; Xiang B
    Mol Oncol; 2020 Jun; 14(6):1282-1296. PubMed ID: 32216017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82.
    Ju H; Hu Z; Wei D; Huang J; Zhang X; Rui M; Li Z; Zhang X; Hu J; Guo W; Ren G
    Cancer Commun (Lond); 2021 Nov; 41(11):1152-1172. PubMed ID: 34498800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0042823 accelerates cancer progression
    Wu T; Sun Y; Sun Z; Li S; Wang W; Yu B; Wang G
    Ann Med; 2021 Dec; 53(1):960-970. PubMed ID: 34124974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells.
    Eckers JC; Kalen AL; Sarsour EH; Tompkins VS; Janz S; Son JM; Doskey CM; Buettner GR; Goswami PC
    Radiat Res; 2014 Oct; 182(4):420-9. PubMed ID: 25229973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition.
    Diab A; Gem H; Swanger J; Kim HY; Smith K; Zou G; Raju S; Kao M; Fitzgibbon M; Loeb KR; Rodriguez CP; Méndez E; Galloway DA; Sidorova JM; Clurman BE
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28287-28296. PubMed ID: 33093209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.